Related Experiment Video

Updated: Jun 11, 2026

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

Azole antimycotics and drug interactions in the perioperative period

Teijo I Saari, Klaus T Olkkola

    Current Opinion in Anaesthesiology
    |July 9, 2010
    PubMed
    Abstract

    Insights

    Azole antifungals, used to prevent fungal infections, can cause dangerous drug interactions with anesthetic drugs. Anesthesiologists must carefully manage these interactions to ensure patient safety during surgery.

    Area of Science:

    • Pharmacology
    • Anesthesiology
    • Infectious Diseases

    Background:

    • Azole antifungals are increasingly used for prophylaxis in intensive care and perioperative settings.
    • Concurrent use of multiple medications for severe illnesses elevates the risk of drug-drug interactions.
    • Previous research indicates azole antifungals pose a significant risk for clinically relevant drug interactions.

    Discussion:

    • This review examines drug-drug interactions between azole antifungals and anesthetic agents during the perioperative period.
    • Azole antifungals are potent inhibitors of cytochrome P450 (CYP) enzymes, affecting drug metabolism.
    • A recent study highlighted a five-fold increased risk of sudden cardiac death with simultaneous use of CYP inhibitors and substrates.

    Key Insights:

    • Azole antifungals significantly inhibit CYP-mediated drug metabolism.
    • Anesthesiologists must be aware of the interaction potential of azole antifungals.
    • Perioperative strategies require adjustment based on patient condition and concomitant medications.

    Outlook:

    • Further research is needed to fully elucidate the mechanisms and clinical impact of these interactions.
    • Development of safer antifungal agents or alternative perioperative management strategies may be warranted.
    • Enhanced vigilance and communication between healthcare providers are crucial for mitigating risks.

    Related Concept Videos

    Antifungal Agents01:15

    Antifungal Agents

    Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
    Drug toxicity: Drug–Drug Interaction01:30

    Drug toxicity: Drug–Drug Interaction

    Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
    Pharmacokinetics: Drug–Drug Interactions01:25

    Pharmacokinetics: Drug–Drug Interactions

    Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
    Combined Effects of Drugs: Synergism01:27

    Combined Effects of Drugs: Synergism

    Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
    Such synergistic combinations...
    Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

    Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

    5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
    Parenteral Anesthetics: Overview01:24

    Parenteral Anesthetics: Overview

    Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.